TAP · Q3 2025 Earnings

Bearish

Molson Coors Beverage Company

Reported November 4, 2025

30-second summary

Rahul Goyal's first quarter as CEO delivered a -2.3% revenue print to $2.97B, a -$2.93B GAAP net loss attributable to MCBC driven by a $3.6B goodwill impairment, and an explicit reaffirmation of every FY2025 metric — at the low end of the range. Americas volumes fell another 4.4% with the segment now down 3.6% in revenue, and the two H2 operating assumptions management itemized only 90 days ago (US industry -4% to -6%, Midwest premium $20-35M incremental) were quietly dropped from the guidance framework. The impairment alone is the loudest disclosure: the prepared remarks tied it to this year's performance and a softer outlook, signaling that management's own internal DCF inputs have moved against the structural story, not the cyclical one.

Headline numbers

EPS

Q3 FY2025

$1.67

Revenue

Q3 FY2025

$2.97B

-2.3% YoY

Gross margin

Q3 FY2025

39.5%

Operating margin

Q3 FY2025

-115.4%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$2.97B	-2.3%	$3.20B	-7.1%
EPS	$1.67	—	$2.05	-18.5%
Gross margin	39.5%	—	40.0%	-50bps
Operating margin	-115.4%	—	18.2%	-13360bps

Guidance

Company reaffirms full-year FY2025 guidance across all key metrics; no material changes to sales, EPS, pre-tax income, or FCF targets despite continued industry softness.

Guidance is issued for both next quarter and the full year. Both may appear below.

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
US Industry Volume Decline (H2)	FY 2025	4% to 6%	Withdrawn — no replacement	—	Withdrawn
Midwest Premium Incremental Costs (H2)	FY 2025	$20-35 million	Withdrawn — no replacement	—	Withdrawn

Reaffirmed unchanged this quarter: Net Sales (3% to 4% decline on a constant currency basis), Underlying Pre-Tax Income (12% to 15% decline on a constant currency basis), Underlying Diluted EPS (7% to 10% decline), Underlying Free Cash Flow ($1.3 billion, plus or minus 10%), Net Interest Expense ($225 million, plus or minus 5%), Capital Expenditures ($650 million, plus or minus 5%), Depreciation and Amortization ($675 million, plus or minus 5%), Underlying Effective Tax Rate (22% to 24%)

Segment performance

Q3 FY2025

Segment	Q3 FY2025	YoY
Americas	$2.26B	-3.6%
EMEA&APAC	$0.721B	+2.4%
Americas Brand Volume Decline	-4.4%	—

Platform metrics

Q3 FY2025

Segment	Q3 FY2025
Financial Volume	19.385 million hectoliters
Brand Volume	20.366 million hectoliters
Net Sales per Hectoliter	$153.46
Price and Sales Mix Impact	2.7% favorable

Profitability

Q3 FY2025

Segment	Q3 FY2025
COGS per Hectoliter Growth	4.1% reported, 3.7% constant currency
Underlying Income Before Income Taxes	$426.0 million
Underlying Effective Tax Rate	22%

Management tone

Customer thesis under Gavin → Industry-cyclical defense (Q2) → New-CEO operational reset (Q3)

The most consequential tonal shift is that the cyclical/structural debate is being relitigated in management's own language. Last quarter Gavin's team framed industry softness as "incremental cyclical" and pointed to consumer confidence and weather. This quarter Rahul lists "health and wellness" and "generational change" as long-standing structural trends before layering on 2025 macro factors (economic impacts, tariffs, immigration). The phrasing is subtle but important: management still states "we continue to believe that the incremental softness in the industry this year is cyclical" — but the word incremental is doing more work now, because Rahul has explicitly expanded the structural base on which it sits. That signals a wider gap between management's public narrative and its internal model than Q2 admitted.

The CEO transition itself was unusually defensive for a first earnings call. Rahul's "in my first 30 days, we have already begun to implement structural changes, both in terms of leadership and operations" is not the language of continuity — it is an explicit signal that the prior strategy was not working. Paired with the announced 400-position Americas restructuring (9% of Americas salaried headcount) and $35-50M of associated charges, this opens optionality (portfolio divestiture, deeper headcount action) that wasn't on the table 90 days ago.

The prepared remarks were notably blunt on Blue Moon: "we haven't seen the success we would like," with the core Belgian White flagged as continuing to be challenged even as non-ALC and high-ABV line extensions show encouraging signs. Combined with the Staropramen and Blue Run intangible writedowns, the message is that the above-premium and beyond-beer parts of the portfolio that were supposed to carry premiumization have themselves been re-marked down.

The $3.6B impairment sits uncomfortably adjacent to the parallel "cyclical softness" framing on the volume side. The charge was booked against the Americas reporting unit — i.e., a write-down of the value of the core US beer business — at the same quarter management is publicly characterizing US industry weakness as cyclical. One of the two narratives is going to give.

Recurring themes management leaned on this quarter:

Macro headwinds (tariffs, immigration, Hispanic consumer pressure) driving cyclical category decline incremental to structural trendsPortfolio rebalancing: economy segment stabilization, above-premium acceleration (Peroni, non-ALC), Blue Moon turnaroundRegional execution and decentralized accountability as antidote to national brand share lossesBeyond-beer as capital deployment priority and premiumization vehicle (Fevertree, non-ALC partnerships)Midwest premium commodity cost inflation as structural margin headwind despite hedgingCost restructuring (400 salaried headcount reduction) enabling marketing reinvestment, not pure cost-cutting

Risks management surfaced:

Midwest premium pricing at all-time highs with continued upside risk; hedging difficult and expensiveU.S. distributor inventory contraction entering 2025; STW expected to trail STR in Q4Category remains in minus 4–6% with regional variation; recovery timeline uncertainHispanic and lower-income consumer spending pressure disproportionately impacting core volumesBlue Moon brand instability despite innovation (non-ALC, high-ABV extensions showing only 'encouraging' progress)

Answers to last quarter's watch list

Whether US industry volume actually runs -4% to -6% in H2 or stays closer to -5% / worsens — The explicit H2 industry assumption was removed from the FY guidance framework this quarter, though Tracey noted in prepared remarks the company continues to expect US industry volume to be down on average 4% to 6% for the second half. Internal estimates put Q3 industry at -4.7%, and Americas brand volume fell 4.4% in Q3, consistent with the middle of last quarter's range. Management's "low end" language on every line implies risk is to the worse side. Status: Resolved in-range, biased negative.

Midwest premium aluminum trajectory — The $20-35M H2 incremental cost line was removed from the explicit guidance framework. Tracey noted MWP traded at the upper end of the assumed 60-75¢/lb range in Q3 and slightly above it in October, with full-year MWP cost increase now expected at the high end of the previously discussed $40-55M range. COGS/HL +3.7% cc indicates input inflation persists. Status: Tracking to the unfavorable end of disclosed assumptions.

US share trend in Q3 — Americas revenue -3.6% with brand volume -4.4%; per management's internal estimates, US volume share was down 40bps in Q3, with relatively better performance in on-premise than off-premise. Share continues to deteriorate, not stabilize.

Resolved negatively

Shipment-to-depletion reversal cadence — Q3 US STWs largely caught up to STRs per Tracey; the financial-vs-brand volume gap reflects the contract-brewing exit and royalty/factored adjustments rather than a Q3 inventory drawdown. The STW-below-STR drawdown is now guided for Q4, with year-end US distributor inventory expected to be lower than year-end 2024 on an absolute basis while days of inventory remain at healthy levels. Status: Resolved as guided, with the actual drawdown deferred into Q4.

FCF defense — Full-year FCF reaffirmed at $1.3B ±10% but with explicit "low end" qualifier, implying ~$1.17B. The buyback narrative is intact for now — Tracey noted the open trading window resumes following this quarter's earnings — but the FCF cushion has narrowed.

Continue monitoring

What to watch into next quarter

Whether Rahul issues a 2026 framework on the Q4 call or defers it. The 30-day-old strategic review and announced restructuring imply a structural reset, but deferring 2026 guidance into a 2026 strategy update would extend the credibility gap by at least two quarters.

Scale of further headcount or portfolio action beyond the announced 400-person reduction. Watch for divestiture chatter (Blue Moon, regional craft, Blue Run-adjacent) or a second restructuring tranche; the prepared-remarks commentary on Blue Moon was notably blunt, and Tracey confirmed a chunk of the announced cuts were already-vacant positions, leaving less 2026 savings than the headline suggests.

Beyond-beer capital deployment. Rahul flagged beyond-beer as an area with portfolio gaps the company intends to fill; any announced transaction will be the first concrete data point on the post-Gavin capital allocation policy.

Whether Q4 brand volume in Americas decelerates further from -4.4% or stabilizes. A -5%+ Q4 print would force a 2026 guide that opens with another double-digit EPS decline.

FY2025 FCF print versus the implied $1.17B low end. Any shortfall here breaks the last intact pillar of the bull case and forces a buyback reassessment.

2026 refinancing approach for the maturing notes Tracey flagged in Q&A, against the stated commitment to remain below 2.5x net leverage at current rates.

Sources

Molson Coors Q3 2025 Earnings Release, filed with SEC on 2025-11-04: https://www.sec.gov/Archives/edgar/data/24545/000002454525000037/tapex99120250930earningsre.htm
Molson Coors Q3 2025 earnings call prepared remarks and Q&A, 2025-11-04.
Tapebrief Q2 2025 brief on TAP (internal, for prior-guide comparison and watch list).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.